The UK is witnessing a significant surge in interest surrounding mind-altering substances. Beyond the common use of psilocybin and LSD, investigators and enthusiasts are increasingly focused on less-charted frontiers, particularly copyright and the budding cannabinoid, cannabigerol. The evolving